Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
06/27/2012 | EP2468731A1 Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component |
06/27/2012 | EP2468730A1 Substituted hydrazide compounds and application thereof |
06/27/2012 | EP2467378A2 Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same |
06/27/2012 | EP2467364A2 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation |
06/27/2012 | EP2467361A1 Novel quinoline-hepcidine antagonists |
06/27/2012 | EP2188263B1 Benzimidazole derivatives used as fxr agonists |
06/27/2012 | EP2013170B1 4-squarylpiperazine derivatives as antiviral agents |
06/27/2012 | EP2007755B1 Fused ring thrombin receptor antagonists |
06/27/2012 | EP2007729B1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments |
06/27/2012 | EP1856042B1 Substituted gamma lactams as therapeutic agents |
06/27/2012 | EP1697352B1 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
06/27/2012 | CN1826323B 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
06/27/2012 | CN102519949A Naked eye visual colorimetric method-based probe for detecting nickel ions and preparation method and applications thereof |
06/27/2012 | CN102516234A Product of Maillard reaction of tryptophan and glucose and its preparation method and application |
06/27/2012 | CN102516229A Fluorescent probe for detecting histidine, precursor thereof and preparation methods of fluorescent probe and precursor |
06/27/2012 | CN102516221A Dibenzyl-macrolide compound based on photoreaction and synthesis method thereof |
06/27/2012 | CN102516217A Compound containing chiral chromanone skeletons and asymmetric synthetic method thereof |
06/27/2012 | CN102516210A Preparation method of 2,3-dicyanofuran compound |
06/27/2012 | CN102516176A Indazole derivatives that inhibit TRPVL receptor |
06/27/2012 | CN102516170A Amide derivatives |
06/27/2012 | CN102516168A Ciprofluoroquinolone C3/C7 dithizone Schiff base, preparation method and application thereof |
06/27/2012 | CN102516149A 1,3,4 - Trisubstituted pyrrole compound and preparation method and application thereof |
06/27/2012 | CN102516147A Method for preparing poly-substituted pyrrolidine derivative |
06/27/2012 | CN102127002B Method for preparing 3,3-diaryl substituted and 3-alkyl-3-aryl substituted oxoindole derivative |
06/27/2012 | CN101993436B Method for preparing imidazole antifungal medicine derivate |
06/27/2012 | CN101967123B 2-cyclopropyl-4-(N-methyl substituted anilino) quinoline compound as well as intermediate, preparation method and application thereof |
06/27/2012 | CN101906097B 1,3-dioxane compounds as well as synthesizing method and medical application thereof |
06/27/2012 | CN101903339B Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
06/27/2012 | CN101595096B Substituted carbinol compound |
06/27/2012 | CN101374833B Novel pyrone-indole derivatives and process for their preparation |
06/27/2012 | CN101133038B HIV inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines |
06/26/2012 | US8207345 Antitumor agents; use in combination with other drugs such as pentamidine |
06/26/2012 | US8207331 Benzazepine derivatives for the treatment of neurological disorders |
06/26/2012 | US8207216 Benzofuran-3-yl(indol-3-yl) maleimides as potent GSK3 inhibitors |
06/26/2012 | US8207183 Inhibitors of IAP |
06/26/2012 | US8207173 Benzimidazoles and analogs thereof as antivirals |
06/26/2012 | US8207166 Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
06/26/2012 | CA2554493C Bicycloester derivative |
06/26/2012 | CA2511970C Urea derivatives useful in the treatment of heart failure |
06/26/2012 | CA2504941C 3-substituted-6-aryl pyridines |
06/26/2012 | CA2438582C Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
06/21/2012 | WO2012083112A2 Cyp11b, cyp17, and/or cyp21 inhibitors |
06/21/2012 | WO2012082817A1 Biarylamide inhibitors of leukotriene production |
06/21/2012 | WO2012082633A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators |
06/21/2012 | WO2012082560A1 Methods of making fused ring compounds |
06/21/2012 | WO2012082506A1 Photochromic compounds and compositions |
06/21/2012 | WO2012082381A1 Indeno- fused ring compounds having photochromic properties |
06/21/2012 | WO2012081692A1 Pyrazole derivative |
06/21/2012 | WO2012081665A1 Substance capable of inhibiting glycine transporter |
06/21/2012 | WO2012081570A1 Lactam compound or a salt thereof, and ppar activator |
06/21/2012 | WO2012080221A1 New compounds for the treatment of neurodegenerative diseases |
06/21/2012 | WO2012080149A1 Novel benzofurane compounds |
06/21/2012 | WO2012080115A1 Strigolactam derivatives and their use as plant growth regulators |
06/21/2012 | WO2012050918A3 Tricyclic fused ring inhibitors of hepatitis c |
06/21/2012 | WO2012035171A3 Sulfonamide compounds |
06/21/2012 | WO2012027712A3 Potent and selective inhibitors of hepatitis c virus |
06/21/2012 | WO2012002741A3 Process for the preparation of hmg-coa reductase inhibitors and intermediates thereof |
06/21/2012 | WO2011051540A9 Androgen receptor modulating compounds |
06/21/2012 | US20120157677 Lactone compounds and materials made therefrom |
06/21/2012 | US20120157498 Substituted enaminocarbonyl compounds |
06/21/2012 | US20120157494 Isoindolyl compounds |
06/21/2012 | US20120157487 Sulfur derivatives as chemokine receptor modulators |
06/21/2012 | US20120157464 Use of azabicycloalkyl derivatives or pyrrolidine-2-one derivatives for the treatment or prevention of ataxia |
06/21/2012 | US20120157463 Chromone derivatives, a process for their preparation and their therapeutic applications |
06/21/2012 | US20120157449 Benzofurane compounds |
06/21/2012 | US20120157433 Heteroaryl Compounds as Kinase Inhibitors |
06/21/2012 | US20120157431 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
06/21/2012 | US20120157412 Substituted Pyrimidinyl Oxime Kinase Inhibitors |
06/21/2012 | US20120157403 Bicyclic and tricyclic derivatives as thrombin receptor antagonists |
06/21/2012 | US20120157314 Novel substituted picolinic acids, salts and acid derivatives thereof, and use thereof as herbicides |
06/21/2012 | US20120156521 Photochromic compounds and compositions |
06/21/2012 | US20120156219 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
06/21/2012 | US20120156213 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor |
06/21/2012 | CA2822044A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators |
06/21/2012 | CA2821893A1 Pyrazole derivative |
06/21/2012 | CA2821392A1 Indeno-fused ring compounds having photochromic properties |
06/21/2012 | CA2820934A1 Strigolactam derivatives and their use as plant growth regulators |
06/21/2012 | CA2820033A1 Photochromic compounds and compositions |
06/21/2012 | CA2819970A1 Novel benzofurane compounds |
06/21/2012 | CA2819171A1 New compounds for the treatment of neurodegenerative diseases |
06/20/2012 | EP2465504A1 Novel 2,3-diamino-quinazolinone derivatives and their medical use |
06/20/2012 | EP2464635A2 Copper catalyzed cycloaddition of organic azides and 1-haloalkynes |
06/20/2012 | EP2464629A1 Selective sphingosine-1-phosphate receptor antagonists |
06/20/2012 | EP2464231A1 Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof |
06/20/2012 | EP2464227A1 Compounds and methods of use thereof |
06/20/2012 | EP2240442B1 Preparation process useful in synthesis of atorvastatin |
06/20/2012 | EP2102169B1 Indazolyl amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
06/20/2012 | EP1960347B1 17-beta-hydroxysteroid dehydrogenase type 3 (17beta-hsd3) inhibitors |
06/20/2012 | EP1745041B1 Quinoxaline inhibitors of the hedgehog signalling pathway |
06/20/2012 | EP1694672B1 Novel chelating agents and highly luminescent and stable chelates and their use |
06/20/2012 | CN102510867A Glycoside derivative and uses thereof |
06/20/2012 | CN102503939A Industrial production process for cis-form propiconazole crude medicament |
06/20/2012 | CN102503895A Preparation method for benzimidazole substituted acrylonitrile derivative |
06/20/2012 | CN102503894A 5-substituted methylene imidazolidine-2, 4-diketone derivative as well as pharmaceutical composition and application thereof |
06/20/2012 | CN102503891A Pyrazole derivatives as 11-beta-hsd1 inhibitors |
06/20/2012 | CN101730688B 2-aryl-5-heterocyclyl-cyclohexane-1,3-dione compounds and their use as herbicides |
06/19/2012 | USRE43481 Diazepan derivatives or salts thereof |
06/19/2012 | US8203005 Manufacturing process for enantiomerically pure 8-aryloctanoic acids as Aliskiren |
06/19/2012 | US8203004 Tetrahydroindole derivatives for treatment of alzheimer's disease |
06/19/2012 | US8202911 Migrastatin analog compositions and uses thereof |